- Home
- GLBS vs BOLD Comparison
GLBS vs BOLD Comparison
Compare GLBS & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBS
- BOLD
- Stock Information
- Founded
- GLBS 2006
- BOLD 2018
- Country
- GLBS Greece
- BOLD United States
- Employees
- GLBS N/A
- BOLD N/A
- Industry
- GLBS Marine Transportation
- BOLD
- Sector
- GLBS Consumer Discretionary
- BOLD
- Exchange
- GLBS Nasdaq
- BOLD Nasdaq
- Market Cap
- GLBS 23.4M
- BOLD 24.4M
- IPO Year
- GLBS 2007
- BOLD 2024
- Fundamental
- Price
- GLBS $1.04
- BOLD $1.16
- Analyst Decision
- GLBS Strong Buy
- BOLD Buy
- Analyst Count
- GLBS 1
- BOLD 3
- Target Price
- GLBS $3.00
- BOLD $4.00
- AVG Volume (30 Days)
- GLBS 27.3K
- BOLD 107.3K
- Earning Date
- GLBS 09-11-2025
- BOLD 08-15-2025
- Dividend Yield
- GLBS N/A
- BOLD N/A
- EPS Growth
- GLBS N/A
- BOLD N/A
- EPS
- GLBS N/A
- BOLD N/A
- Revenue
- GLBS $35,776,000.00
- BOLD N/A
- Revenue This Year
- GLBS $5.01
- BOLD N/A
- Revenue Next Year
- GLBS $27.86
- BOLD N/A
- P/E Ratio
- GLBS N/A
- BOLD N/A
- Revenue Growth
- GLBS 17.92
- BOLD N/A
- 52 Week Low
- GLBS $0.99
- BOLD $1.00
- 52 Week High
- GLBS $2.21
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- GLBS 37.36
- BOLD N/A
- Support Level
- GLBS $1.00
- BOLD N/A
- Resistance Level
- GLBS $1.23
- BOLD N/A
- Average True Range (ATR)
- GLBS 0.06
- BOLD 0.00
- MACD
- GLBS -0.01
- BOLD 0.00
- Stochastic Oscillator
- GLBS 16.00
- BOLD 0.00
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.